At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity
In Brief
A clinical study evaluating Educational curriculum, Weight loss Application, and 3 other interventions for Obesity &Amp;Amp;Amp; Overweight and 2 related conditions. Active but no longer recruiting, targeting 226 participants across 1 site.
Detailed Summary
The goal of this study is to examine the relationship in individuals with overweight/obesity and endocrine disrupting chemical (EDC) exposure through a two-armed, randomized clinical trial. The main questions this study aims to answer are: 1. If MM's 12-week EDC intervention program (EDC testing and report-back, EDC reduction curriculum) can reduce weight? 2. If a 12-week validated digital weight loss program can reduce EDC exposures? 3. What is the effectiveness of the two interventions at reducing weight and urinary EDC metabolites? Participants will be assigned to one of these two arms. Participants will collect their urine and blood samples pre- and post-intervention, and will take a comprehensive exposure survey before sending back their samples. This exposure survey will ask about participant's weight loss literacy, environmental health literacy, product use, diet, and lifestyle behaviors.
Study Details
Timeline
Interventions
A self-directed online interactive curriculum of EDC material, with access to live coaches and an online forum.
A paid, self-directed weight loss application.
Mail-in urine samples tested for metabolites of bisphenols, phthalates, parabens, and oxybenzone.
Mail-in blood samples tested for clinical biomarkers.
Self-reported weight loss.